Skip to main content

Key Product Details

Species Reactivity

Human, Mouse

Applications

Western Blot

Label

Biotin

Antibody Source

Monoclonal Mouse IgG2A Clone # OTI4C2

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Recombinant protein fragment corresponding to amino acids 1-296 of human NKRF (NP_060014) produced in E.coli.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2A

Applications for NKRF Antibody (OTI4C2) [Biotin]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: NKRF

The NKRF gene encodes a transcription factor that interacts with specific negative regulatory elements (NREs) to mediatetranscriptional repression of certain NK-kappa-B-responsive genes. The protein localizes predominantly to thenucleolus with a small fractio

Alternate Names

ITBA4NFkB-repressing factor, NF-kappaB repressing factor, NFKB repressing factor, NRFNF-kappa-B-repressing factor, Protein ITBA4, Transcription factor NRF

Gene Symbol

NKRF

Additional NKRF Products

Product Documents for NKRF Antibody (OTI4C2) [Biotin]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for NKRF Antibody (OTI4C2) [Biotin]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...